This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Conlon, J A Articles by Lo, R Y Search for Related Content PubMed PubMed Citation Articles by Conlon, J A Articles by Lo, R Y

 Previous Article  |  Next Article 

Infect Immun. 1991 February; 59(2): 587-591

Efficacy of recombinant leukotoxin in protection against pneumonic challenge with live Pasteurella haemolytica A1.

Department of Veterinary Microbiology, University of Guelph, Ontario, Canada.

ABSTRACT

The recombinant leukotoxin (rLKT) of the bacterium Pasteurella haemolytica A1 was examined for its ability to protect cattle from experimental challenge with logarithmic-phase P. haemolytica. Six different vaccines were utilized in the experiment: P. haemolytica culture supernatant, P. haemolytica culture supernatant enriched with rLKT, rLKT alone, P. haemolytica culture supernatant enriched with Escherichia coli supernatant not containing LKT, E. coli supernatant alone, and phosphate-buffered saline. rLKT alone showed no protective capacity against development of clinical signs of respiratory disease or against development of postmortem lung lesions after experimental challenge. It was, however, shown to enhance the efficacy of the culture supernatant vaccine and decrease clinical signs and pneumonic lesions. The complexity of protective immunity in this disease is emphasized in this study, and, although LKT is an important virulence factor of the organism, an immune response to LKT alone does not protect animals against disease.

This article has been cited by other articles:

• Ayalew, S., Confer, A. W., Blackwood, E. R. (2004). Characterization of Immunodominant and Potentially Protective Epitopes of Mannheimia haemolytica Serotype 1 Outer Membrane Lipoprotein PlpE. Infect. Immun. 72: 7265-7274 [Abstract] [Full Text]  
• Shouldice, S. R., Dougan, D. R., Williams, P. A., Skene, R. J., Snell, G., Scheibe, D., Kirby, S., Hosfield, D. J., McRee, D. E., Schryvers, A. B., Tari, L. W. (2003). Crystal Structure of Pasteurella haemolytica Ferric Ion-binding Protein A Reveals a Novel Class of Bacterial Iron-binding Proteins. J. Biol. Chem. 278: 41093-41098 [Abstract] [Full Text]  
• Lee, R. W. H., Strommer, J., Hodgins, D., Shewen, P. E., Niu, Y., Lo, R. Y. C. (2001). Towards Development of an Edible Vaccine against Bovine Pneumonic Pasteurellosis Using Transgenic White Clover Expressing a Mannheimia haemolytica A1 Leukotoxin 50 Fusion Protein. Infect. Immun. 69: 5786-5793 [Abstract] [Full Text]  
• Zeng, H., Pandher, K., Murphy, G. L. (1999). Molecular Cloning of the Pasteurella haemolytica pomA Gene and Identification of Bovine Antibodies against PomA Surface Domains. Infect. Immun. 67: 4968-4973 [Abstract] [Full Text]  
• Pandher, K., Confer, A. W., Murphy, G. L. (1998). Genetic and Immunologic Analyses of PlpE, a Lipoprotein Important in Complement-Mediated Killing of Pasteurella haemolytica Serotype 1. Infect. Immun. 66: 5613-5619 [Abstract] [Full Text]